MIRA
INFORM REPORT
|
Report Date : |
22.05.2007 |
IDENTIFICATION DETAILS
|
Name : |
CHAS. A. |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
1971 |
|
|
|
|
Legal Form : |
Partnership |
|
|
|
|
Line of Business : |
Manufacture & Export Of
Human Medicine |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Business Name
CHAS. A.
Full Address
|
Registered Address |
Factory Address |
|
|
Plot No. 7, Sector
No. 23, Korangi Industrial Area, Karachi-74900, |
|
Tel |
92 (21) 4536424,
30 (6 Lines) |
|
Tel |
92 (21) 5062812, 4 |
|
Fax |
92 (21) 4531717,
4557379 |
|
Fax |
92 (21) 5062893 |
|
|
|
|||
Short Description Of
Business
|
Nature of Business |
Manufacture & Export Of
Human Medicine |
|
Year Established |
1971 |
Branches
|
Address |
|
|
Tel # |
92
(42) 5863018 |
|
Fax # |
92
(42) 5864148 |
Legal Status
Subject Company was established as a Partnership business in 1971
Details of Managing
Partner / Partners
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Khalil Ahmed Nanitalwala Mr. Salman Khalil Mr. Khurram Khalil Mr. Junaid Khalil |
Pakistani Pakistani Pakistani Pakistani |
53, Faran Housing
Society, Shaheed -e- 53, Faran Housing
Society, Shaheed -e- 53, Faran Housing
Society, Shaheed -e- 53, Faran Housing
Society, Shaheed -e- |
Business Business Business Business |
Managing Partner Partner Partner Partner |
Associates
Subsidiary
None
Associated Companies
W. Woodwards Pak (Pvt.) Ltd.
Marriana International
KN Academy
Products
Injections, Capsules, Syrups, Tablets, Drops & Topicals by their brand name of CAMOCEP, CAMOCID, CAMOPLEX SUPER-1000, CAMOTAREN, CAMOZYME, CAMPOLEX LYSINE, DARAGON, DEXAMETHASONE TABS, DOZAMET, FOLIC ACID, HEPTOCAM, LAXACAM, LORIVAL, MALAGON, MEDROX, MENDOZA, MENDOZAPLEX, METHYL SALICYLATE, POVIDIDE, PROCAM, RITADINE, RONUVIT, SIMCAM, SINDOSE, SIROLINE, THIAVIT, TRANSCAM, VITA 6
Number of Employees
160 - 180
Annual Production
Volume
The capacity and production of the company’s plant is
indeterminable as it is multi-product and involves varying processes of
manufacture.
Annual Sales Volume
|
Year |
In Pak Rupees |
|
2006 |
200,000,000/-(Estimated) |
Customers
Mainly Hospitals(Government and Private), Clinics, Pharmacies,
Specialists, Consultants, Physicians, Super Markets & General Stores.
Exporting Countries
Mainly to
Bankers
MCB Bank Ltd,
Faysal Bank Limited,
Bank Alfalah Limited,
Standard Chartered
Habib Metropolitan Bank Limited,
Memberships
Foreign Exchange
Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 60.82 |
|
|
1 |
Rs. 119.50 |
|
Euro |
1 |
Rs. 81.65 |
Comments
Medicam Group enjoys
good reputation and well connected peoples. Directors are highly respectable, well experienced, resourceful and
influential in the Government as well as in the Political circles. The Company
is well known for its good Quality Products in Pharmaceutical Sector in
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)